IRIS
MALERBA, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.454
EU - Europa 5.395
AS - Asia 3.944
SA - Sud America 812
Continente sconosciuto - Info sul continente non disponibili 288
AF - Africa 126
OC - Oceania 6
Totale 17.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.203
RU - Federazione Russa 1.467
SG - Singapore 1.206
IE - Irlanda 1.099
CN - Cina 892
HK - Hong Kong 681
IT - Italia 678
BR - Brasile 614
DE - Germania 586
VN - Vietnam 545
SE - Svezia 398
UA - Ucraina 393
FR - Francia 340
GB - Regno Unito 159
BD - Bangladesh 146
CA - Canada 106
IN - India 101
KR - Corea 83
AR - Argentina 75
ID - Indonesia 64
FI - Finlandia 57
MX - Messico 57
NL - Olanda 48
BJ - Benin 46
EC - Ecuador 39
PL - Polonia 35
JP - Giappone 32
ZA - Sudafrica 32
IQ - Iraq 28
CO - Colombia 27
PK - Pakistan 25
SA - Arabia Saudita 23
AT - Austria 22
ES - Italia 22
BE - Belgio 20
TR - Turchia 18
JM - Giamaica 17
VE - Venezuela 16
CL - Cile 15
CR - Costa Rica 14
PH - Filippine 13
LT - Lituania 12
CZ - Repubblica Ceca 11
EU - Europa 11
GT - Guatemala 11
UZ - Uzbekistan 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
EE - Estonia 8
IR - Iran 8
MA - Marocco 8
PY - Paraguay 8
CH - Svizzera 7
EG - Egitto 6
MY - Malesia 6
PE - Perù 6
UY - Uruguay 6
AU - Australia 5
JO - Giordania 5
KE - Kenya 5
NP - Nepal 5
PR - Porto Rico 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
SV - El Salvador 5
TN - Tunisia 5
TW - Taiwan 5
AL - Albania 4
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
ET - Etiopia 4
GP - Guadalupe 4
KG - Kirghizistan 4
NI - Nicaragua 4
PA - Panama 4
QA - Qatar 4
TH - Thailandia 4
AM - Armenia 3
BS - Bahamas 3
DO - Repubblica Dominicana 3
HN - Honduras 3
LV - Lettonia 3
AO - Angola 2
BB - Barbados 2
BQ - ???statistics.table.value.countryCode.BQ??? 2
GE - Georgia 2
GR - Grecia 2
KW - Kuwait 2
KZ - Kazakistan 2
MN - Mongolia 2
NO - Norvegia 2
OM - Oman 2
SN - Senegal 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BF - Burkina Faso 1
BG - Bulgaria 1
Totale 16.731
Salva come PNG Salva come JPEG
Città #
Dublin 1.092
Jacksonville 755
Hong Kong 674
San Jose 671
Singapore 451
Ashburn 435
Council Bluffs 386
Dearborn 366
Beijing 262
Los Angeles 168
Moscow 164
Ho Chi Minh City 158
Lauterbourg 150
Columbus 145
Princeton 144
Hanoi 143
Wilmington 143
Lawrence 142
San Mateo 121
Santa Clara 112
Ann Arbor 94
New York 87
Buffalo 79
Seoul 78
Chandler 71
Milan 69
Phoenix 66
São Paulo 64
Orem 55
Dallas 52
Novara 49
Redondo Beach 47
Cotonou 46
Houston 46
Rome 41
Munich 39
Piemonte 39
Seattle 39
St Louis 39
Helsinki 38
Turin 34
Atlanta 30
Mexico City 30
Chennai 27
Guangzhou 27
Warsaw 27
Denver 26
Haiphong 24
Jakarta 24
Montreal 24
Rio de Janeiro 24
Nanjing 23
Nuremberg 23
Tokyo 23
Da Nang 22
San Francisco 22
Stockholm 22
Hefei 21
Philadelphia 21
Torino 21
Brooklyn 20
Frankfurt am Main 20
London 20
Brussels 19
Quito 19
Chicago 18
Dong Ket 18
North Bergen 18
Norwalk 18
Tianjin 18
Toronto 18
Woodbridge 18
Boston 17
Schaumburg 17
Boardman 16
Medina 16
Shanghai 16
Viggiano 16
Johannesburg 15
Manchester 15
Andover 14
Falkenstein 14
Kunming 14
Turku 14
Amsterdam 13
Assago 12
Hangzhou 12
Mumbai 12
Nanchang 12
Palermo 12
Poplar 12
Belo Horizonte 11
Charlotte 11
Miami 11
Naples 11
Thái Bình 11
Berlin 10
Brno 10
Kingston 10
Olathe 10
Totale 8.903
Salva come PNG Salva come JPEG
Nome #
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score 354
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 275
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 214
Ambroxol in the 21st century: pharmacological and clinical update 211
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 205
Interrelationship between COVID-19 and Coagulopathy: Pathophysiological and Clinical Evidence 203
Change over time of COVID-19 hospital presentation in Northern Italy 175
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 173
Sleep apnea and psoriasis: A cohort study 171
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 169
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 169
Role of beta-blockers in patients with COPD: current perspective. 163
DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases 158
Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction 155
Identification of Key Phospholipids That Bind and Activate Atypical PKCs 155
Interrelationship among Obstructive Sleep Apnea,Renal Function and Survival: A Cohort Study 151
[Alpha 1-antitrypsin deficiency: the Brescia clinical study]. FT Il deficit di alpha 1-antitripsina: lo studio clinico di Brescia. 148
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons 136
Acute exacerbation of idiopathic pulmonary fibrosis: lessons learned from acute respiratory distress syndrome? 133
Dupilumab and tezepelumab in severe refractory asthma: new opportunities 131
Association of FEF25-75% Impairment with Bronchial Hyperresponsiveness and Airway Inflammation in Subjects with Asthma-Like Symptoms 131
Age-Related Increase of Airway Neutrophils in Older Healthy Nonsmoking Subjects 128
Analysis of mitochondrial DNA alteration in new phenotype ACOS 128
Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases 127
Circulating Peptidome Is Strongly Altered in COVID-19 Patients 124
Acute respiratory distress following intravenous injection of trichloroethylene 124
Late Breaking Abstract- New imaging approach to evaluate the in vivo administration of nanostructured mycophenolic acid in a preclinical model of SSC-ILD 121
ACUTE VENTILATORY AND GAS-EXCHANGE EFFECTS OF A NEW BETA-2 AGONIST, BROXATEROL, IN ASTHMATICS 120
EXHALED NITRIC OXIDE AS A MARKER OF LUNG INVOLVEMENT IN CROHN'S DISEASE 120
A randomized trial of cefepime and ceftazidime for the treatment of community-acquired pneumonia 119
Comorbid insomnia and obstructive sleep apnea (Comisa): Current concepts of patient management 118
Exosomes in chronic respiratory diseases 118
[Pharmacologic control of breathing]. FT Controllo farmacologico della ventilazione. 116
Biological pathways and mechanisms linking COPD and cardiovascular disease 114
Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: A model to study tuberculosis immunity 114
Aging and induced-sputum cells 113
Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research 109
DOXAZOSIN IN THE TREATMENT OF HYPERTENSION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 109
Exhaled Nitric Oxide as a Biomarker in COPD and Related Comorbidities 107
Determinants of smoking status in a sample of outpatients afferent to a tertiary referral hospital 107
Airway hyperresponsiveness in a large group of subjects with alpha(1)-antitrypsin deficiency: a cross-sectional controlled study 105
Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients. 104
COVID-19 infection is a significant risk factor for death in patients presenting with acute cholecystitis: a secondary analysis of the ChoCO-W cohort study 103
Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions 103
Exhaled nitric oxide levels in systemic sclerosis with and without pulmonary involvement 103
Identification of IL-17F/frequent exacerbator endotype in asthma 103
[Severe alpha 1-antitrypsin deficiency: cross sectional clinical study]. FT Grave deficit di alpha 1-antitripsina: studio clinico trasversale. 103
Prolonged higher dose methylprednisoloneversusconventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 102
Folic acid in general medicine and dermatology 102
Ineffectiveness of intravenous beta(2)-agonists on improving exercise tolerance in patients with reversible chronic airway obstruction 102
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 102
Long term adjustment of stable asthma treatment with fractional exhaled nitric oxide and sputum eosinophils 100
Bronchial Progenitor Cells in Obstructive and Neoplastic Lung Disease: A Pilot Study 99
[General practitioner and respiratory medicine specialist. A survey on the management of the asthmatic patient]. FT Indagine conoscitiva sul rapporto tra medico di medicina generale e specialista in medicina respiratoria nella gestione clinica del paziente asmatico. 99
[Infective pneumopathies in old age]. FT Pneumopatie infettive in eta geriatrica. 99
The respiratory syncytial virus prefusion F protein vaccine attenuates the severity of respiratory syncytial virus‐associated disease in breakthrough infections in adults ≥60 years of age 96
[Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study]. Alterazioni del ritmo cardiaco e terapia beta-2-agonista a lento rilascio (per via orale) in pazienti asmatici. Studio Holter. 96
Triple inhaled therapy for chronic obstructive pulmonary disease 95
Dupilumab for the treatment of asthma 95
Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients. 95
Analysis of the fungal microbiome in exhaled breath condensate of patients with asthma. 94
SUB-CLINICAL LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN EARLY STAGE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 94
Glucocorticoid-induced osteoporosis in asthma and respiratory diseases 93
Exhaled nitric oxide levels in alpha-1-antitrypsin PiMZ subjects 93
Biological investigations | [Indagini biologiche] 93
Investigational beta-2 adrenergic agonists for the treatment of chronic obstructive pulmonary disease. 92
Non-Invasive Biomarkers of Lung Inflammation in Smoking Subjects 92
SEVERE INTRAVASCULAR HAEMOLYSIS AS DELAYED MANIFESTATION OF PERIVALVULAR LEAK IN PATIENTS WITH MITRAL VALVE REPLACEMENT: A REPORT OF TWO CASES 92
[Respiratory effects of antihypertensive agents acting on alpha adrenergic receptors]. Effetti respiratori dei farmaci antiipertensivi che agiscono sui recettori alfa adrenergici. 92
Narrow-band ultraviolet b phototherapy in psoriasis reduces pro-inflammatory cytokine levels and improves vitiligo and neutrophilic asthma 92
Biological investigations in pulmonology [Indagini biologiche in pneumologia] 92
[Tracheal stenosis due to metastatic adenopathic compression from breast carcinoma]. FT Stenosi tracheale per compressione adenopatica metastatica da carcinoma della mammella. 91
Vilanterol trifenatate for the treatment of COPD. 91
The Combined Impact of Exhaled Nitric Oxide and Sputum Eosinophils Monitoring in Asthma Treatment: A Prospective Cohort Study 91
Potential role of diacylglycerol kinases in immune-mediated diseases 91
Predictive Markers of Bronchial Hyperreactivity in a Large Cohort of Young Adults With Cough Variant Asthma 90
UPPER EXTREMITY DEEP VEIN THROMBOSIS AS AN UNCOMMON COMPLICATION OF PACEMAKER IMPLANTATION: A CASE REPORT 90
THE POTENTIAL THERAPEUTIC ROLE OF POTASSIUM CHANNEL MODULATORS IN ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE 90
Critical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electronic cigarettes 90
Usefulness of Exhaled Nitric Oxide and Sputum Eosinophils in the Long-term Control of Eosinophilic Asthma 89
Psoriasis and risk of myocardial infarction 89
Cardiac arrhythmia monitoring during bronchial provocation test with methacholine 89
Potential role of hematological parameters in patients with chronic obstructive pulmonary disease: current point of view 89
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 89
Investigational prostaglandin D2 receptor antagonists for airway inflammation. 88
C-REACTIVE PROTEIN AND MARKERS FOR THROMBOPHILIA IN PATIENTS WITH CHRONIC PLAQUE PSORIASIS 88
[Rhinitis and asthma]. FT Rinite e asma. 87
Growth hormone response to growth hormone-releasing hormone is reduced in adult asthmatic patients receiving long-term inhaled corticosteroid treatment 87
Lower limb deep vein thrombosis in COVID-19 patients admitted to intermediate care respiratory units 87
Sleep Deprivation, Immune Suppression and SARS-CoV-2 Infection 86
Micellar electrokinetic chromatography determination of desmosine in urine from patients with chronic lung disease. 86
PNEUMOLOGY 86
Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD 86
Platelet activation as a novel mechanism of atherothrombotic risk in chronic obstructive pulmonary disease 85
Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. 85
Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects 85
Effect of two beta(2)-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis 85
Lung Involvement in Patients with Ulcerative Colitis: Relationship between Exhaled Nitric Oxide and Lung Function 84
EXHALED NITRIC OXIDE IS RELATED TO BRONCHIAL EOSINOPHILIA AND AIRWAY HYPERRESPONSIVENESS TO BRADYKININ IN ALLERGEN-INDUCED ASTHMA EXACERBATION 83
Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects. 83
Totale 11.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.270
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022785 0 0 0 93 63 21 53 27 98 19 124 287
2022/20231.707 156 89 61 20 31 77 61 70 1.049 13 60 20
2023/2024707 43 47 32 25 130 12 81 20 13 7 150 147
2024/20251.863 23 15 42 28 36 114 181 148 530 265 102 379
2025/20266.894 247 230 553 1.093 584 482 893 1.039 523 606 373 271
2026/20272.289 435 706 539 609 0 0 0 0 0 0 0 0
Totale 17.025